The Use of Albendazole in a case of Hydatid Cyst with Multiple Organ Involvement

Year 1999, Volume: 12 Issue: 3, 142 - 145, 02.06.2016

İlknur Erdem , Nurgül Ceran Paşa Göktaş Emin Karagül Mustafa Sarıtaş

Abstract

In the treatment of hydatid cysts, surgical intervention is still the primary method. In cases with multiple organ involvement, medical treatment with the benzimidazole group drugs (Mebendazole- Albendazole) has been reported to reveal promising results. We reported this case because of multiple organ involvement including posterior fossa involvement which is quite rare. We also discussed treatment results and drug efficacy with the literature review. A 24 year old female presented to our department with complaing of headache, cough and a foul smelling fluid regurgitating from the mouth that was of 15 days duration. Multiple cysts of various sizes and location were revealed on the chest x-ray. Multiple cysts in the liver, spleen, and kidneys were seen on the abdominal ultrasonography, and a cystic formation in the posterior cranial fossa was observed on the cranial computerized tomography. The indirect hemagglutination test was positive at the titration of 1 :92400. Five courses of therapy each lasting four weeks with 800 mg/day Albendazole led to the dissolution of the cysts in the brain, kidneys and decrease in the number and / or size of the cysts in the spleen and liver. The contents of the cysts in the lungs were drained with the cyst wall being visible on x-ray.

Keywords

Albendazole, Multiple organ involvement, Hydatid eysi

References

• Schantz PN, Kramer JNM. Larva/ cestode infectfons: Cysticercosis and Echİnococcosis. Cur Opin lı1fec.t Dis. 1985;8:􀐿342-349.
• Gezen r. Baysefer A., Jfök-;el T,. et al. ffydalid cyst of the brain, CUn lnfect Dis 1995;21:9.38-942.
• Bezzi M. Teggi A Rosa Dl': et aL Abdominal fıydatfd disease: US findings during medical treatment. Radiology 1987:162:91-95.
• Klng en Cestode.s. En: MandeIJ OL, Bennett JE, Dolfn R. Principles and pmctice of infecüous diseases. 4 th ed, New Yor.k: Churchill Uvingstone, 1995:2544-2552.
• Norris Dl, Dykes PW, Marriner S, et al. Albendazofe.objective evidence of response in human hydatid disease. JAMA 1985;253:205:3-2057.
• Saimot AQ, Meulemans A,. Cremyeux AC, et al. Albendazole as a potential treatment tor human hydatidosis. Lancet I 983,2:652-656.
• Schantz P1'1. Effective medical tn:,atment !Or hydaild disease. JA.ııtA !985:253:2095-2097.
• Teggi A, Lastilla t1G, Ra."ia DF et al. Thempy of human hydatid disease with mebendazole and albendazole. Antimicmb Agents Chemother 1993:37, 1679-1684.
• Singounas e, Leventis AS, Sakas DE, et al. Successful treatment of intracerebrai hydatid cysts wfth albendazole: Case repoıt and revtew of the literature. tfeurosurgery J 992/:51 :57 I-575.
• Khuroo MS, Dar ns, Yattoa ON ,et al. Pen::utaneous droinage ver.sus albendazole therapy in hepatic hydatidosls; A prospeclive, randomized study. aastroentero}agy 199:5; 104: 1452w J 459.